Sign In
Buy EDSA
$5.11
-0.140 (-2.67%)
At Close: Jul 31, 2026
Edesa Biotech Reports Quarterly Financial Results
08:05pm, Wednesday, 14'th Aug 2019
TORONTO, ON / ACCESSWIRE / August 14, 2019 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, today reported financial results for the three and six months ended June 30,
Edesa Biotech Completes Manufacturing for Upcoming Dermatitis Study
11:30am, Thursday, 25'th Jul 2019
TORONTO, ON / ACCESSWIRE / July 25, 2019 / Edesa Biotech, Inc. (NASDAQ: EDSA), a clinical-stage biopharmaceutical company, reported today that the company has completed the manufacturing of its lead d
Edesa Biotech (EDSA) Stock Rockets Higher on Dermatitis Study Approval
04:12pm, Thursday, 20'th Jun 2019
Edesa Biotech (NASDAQ:EDSA) stock is flying higher on Thursday after getting approval from the U.S. Food and Drug Administration (FDA).Source: Shutterstock The approval from the FDA is for Edesa Biote
Edesa Biotech Receives Approval to Proceed with U.S. Clinical Study
11:30am, Thursday, 20'th Jun 2019
TORONTO, June 20, 2019 /PRNewswire/ -- Edesa Biotech, Inc. (Nasdaq: EDSA), a clinical-stage biopharmaceutical company, reported today that the U.S. Food and Drug Administration has notified the compa
